Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-023530
Filing Date
2021-02-16
Accepted
2021-02-16 13:15:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm216774d1_sc13g.htm SC 13G 37244
  Complete submission text file 0001104659-21-023530.txt   38572
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91536 | Film No.: 21635414
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 PLEASANT LANE OYSTER BAY NY 11771
Business Address
Asaithambi Arunkumar (Filed by) CIK: 0001813377 (see all company filings)

Type: SC 13G